The sudden progression of the biopharmaceutical industries represents the rising importance of the biomanufacturing as the chief procedure for the evolution and manufacture of the biological-based products, this is called the next-generation biomanufacturing market.
Next-generation biomanufacturing products are developed to provide consistent services that is better as compared to the first generation biomanufacturing products both in terms of quality and efficiency.
Next-generation biomanufacturing market is focusing towards the use of single-use products such as single-use bio-containers and single-use bio-reactors, this is the most popular trends in the next generation biomanufacturing market.
This has led to the large numbers of advantages in the next-generation biomanufacturing market such as the reduced risk of contamination of products, adoption of cost savings facilities.The outbreak of novel coronavirus is believed to have an enduring impact on biopharmaceutical manufacturing.
Due to the COVID-19 pandemic, development of vaccines has become the main goal of the biomanufacturing industries. The development of advanced vaccines will also influence the growth of the biopharmaceutical industry post coronavirus pandemic.
Scientists and engineers are now focusing to develop the next-generation biomanufacturing functioning that can produce advanced vaccines in a cost-effective manner. They are also focusing on the quantities of the vaccines which would be needed to respond to future outbreaks and pandemic.
Rising number of biopharmaceutical companies across the world is expected to drive the next generation bio-manufacturing market in the forecast period. The need for advanced biomanufacturing to fulfil the demand of the patients is expected to boost up the growth of the next-generation biomanufacturing market.
Increasing investment of government and private organizations on the development of the innovative technology is expected to further boost various opportunities which in turn will lead to the growth of next-generation biomanufacturing market.
Many companies innovating products to enter into the next-generation biomanufacturing market, various novel next-generation biomanufacturing products are expected to be launched which would drive the growth of the next-generation biomanufacturing market.
Increasing awareness among the people regarding the benefits of the next-generation bio-manufacturing market would lead to the growth of the market.Based on the type, upstream biomanufacturing is expected to be the preferred process in the global next-generation biomanufacturing market.
Based on the application, the monoclonal antibody product segment is expected to dominate the next-generation due to high rate of products approval. Monoclonal antibodies to be followed by vaccines due to the current outbreak of novel coronavirus.
Based on end-user, biopharmaceutical companies are expected to be the major contributor of the revenue in the next-generation biomanufacturing market.North America is expected to dominate the next-generation biomanufacturing market due to the higher adoption of advanced technology and the prevalence of manufacturing industries in the region.
North America is expected to be followed by Europe. Asia-Pacific is expected to be the fastest-growing next-generation biomanufacturing market due to the rising population in countries like India and China.
Latin America market is expected to experience the constant growth rate in the next-generation bio-manufacturing market whereas the Middle East & Africa expected to be the least profitable market due to lower adoption of advanced technology.
The major players operating in the global next-generation biomanufacturing market are:
- Sartorius AG
- Merck &Co.
- Meissner Filtration
- ESCO Group LLC
- Solaris Biotechnology Applikon Biotechnology
- GEA Group AG
- PBS Biotech Inc.,
- bbi-biotech GmbH
- bbi-biotech GmbH
The report covers exhaustive analysis on:
- Next-generation biomanufacturing Market Segments
- Next-generation biomanufacturing Market Dynamics
- Historical Actual Market Size, 2015 - 2019
- Next-generation biomanufacturing Market Size & Forecast 2020 to 2030
- Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Market Drivers and Restraints
Regional analysis includes
- North America
- Latin America
- Asia Pacific
- Middle East & Africa
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current and projected industry size recent industry trends
- Key Competition landscape
- Strategies for key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
next-generation bio-manufacturing market segment
The global next-generation bio-manufacturing market has been segmented based on workflow type, application and end-user.
By workflow type:
- Upstream Biomanufacturing Workflow
- Single-Use Upstream Biomanufaturing Workflow
- Downstream Biomanufaturing Workflow
- Monoclonal Antibodies
- Recombinant protein
- Biopharmaceutical Companies
- Research Institutions
- Contract Research Organizations
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.